Getein Biotech, Inc. Class ASSE: 603387

Announcement on Termination of Listing on National Equities Exchange and Quotations by Holding Subsidiary Wuhan King Diagnostic Technology Co., Ltd.

· Issued by Getein Biotech, Inc. Class A via Shanghai Stock Exchange
Announcement on Termination of Listing on National Equities Exchange and Quotations by Holding Subsidiary Wuhan King Diagnostic Technology Co., Ltd.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis